The recent development of a dual-action therapy for aggressive oral cancer has the potential to completely change the landscape of treatment for this deadly disease. By simultaneously targeting two different pathways involved in tumor growth and metastasis, this new approach offers hope for improved outcomes and survival rates. But just how effective is this therapy? What are the potential drawbacks or side effects? And most importantly, how soon can patients expect to have access to this groundbreaking treatment? These are just a few of the pressing questions that researchers and medical professionals will need to address as they work to bring this innovative therapy to the forefront of cancer care.

Read Full Article Here

source: Phys.org